Cheng Tao Liang

Cheng graduated from the University of New South Wales in 2017 with BAdvSci Honours Class 1, majoring in Neuroscience and Psychology. Since his graduation, he has been involved in several neuroimaging research projects investigating brain-behaviour associations in neurodegenerative diseases as a Research Assistant for 2 years.

Cheng is currently a PhD candidate at the University of Sydney. His current interest focuses on understanding the dynamic structural brain and cognitive changes to find reliable multi-modal brain imaging biomarkers associated with different trajectories in dementia syndromes. His PhD aims to use his neuroimaging expertise to improve early assessment of dementia syndromes, improving diagnosis and prognosis.

Forefront Group: FRONTIER Research Group

Supervisors:

Dr Ramon Landin-Romero, Prof. Olivier Piguet and Prof. Fernando Calamante

Affiliate Organisations:

The University of Sydney

Expertise:

  • Neuroimaging

Neurodegeneration of interest:

Frontotemporal dementia, Alzheimer’s disease

Specific Skills:

  • Statistical modelling
  • Multimodal neuroimaging analysis

Project - Improving diagnosis and prognosis in dementia using multimodal brain imaging (2019-Current)

Research Project Objectives

  • To characterise syndrome-specific changes in brain integrity using multimodal imaging approaches at disease presentation and over time.
  • To characterise and predict brain imaging changes of individual patients across different modalities

Project tag with a disease

Dementia, FTD, AD

Research Project Description

The diagnosis and prognosis of dementia is challenging due to the ambiguity of early symptoms and heterogeneous pathologies, delaying relevant and accurate interventions. The overarching aim of Cheng’s PhD project is to improve diagnosis and prognosis by characterising the structural and functional brain changes across dementia syndromes using multimodal neuroimaging.

Cheng’s PhD project aims to unravel the phenotypic and temporal heterogeneity in dementia by developing neuroimaging models to predict disease trajectories in individual patients. To obtain an accurate biomarker that is clinically relevant, the models from this research will be applied (i) across different dementia syndromes with varying pathologies, (ii) in a clinical setting and (iii) longitudinally to characterise disease progression.

Methods

Cheng’s PhD combines multivariate neuroimaging models using structural T1 and diffusion weighted magnetic resonance imaging to characterise the dynamic changes between cortical structure and connectivity in the brain (Figure 1). To investigate longitudinal changes across these modalities, linear mixed effects modelling will be used to establish differences across syndrome-specific groups, and a multifactorial causal model will be used to derive individual trajectories. These methods will enable the customisation of medical decisions for individual patients.

Infographic / Medical Diagram / Scientific Diagram / Picture

Figure 1. Preliminary methods and results showing cortical atrophy and degeneration of white matter tracts over time in a single FTD patient.